Patents Assigned to Minu, LLC
-
Patent number: 7744860Abstract: A method for reducing irritancy of ascorbic acid administered to a biological surface for anti-angiogenic, anti-oxidant, anti-inflammatory and other effects. It has been discovered that pH neutralized ascorbic acid retains the efficacy of non-pH neutralized ascorbic acid in reducing neovascularization, providing an anti-oxidant effect, etc. but is less irritating and thus enhances patient comfort and compliance. It may be administered into or on the eye, on skin, into a body cavity, etc. either alone or with other agents.Type: GrantFiled: October 19, 2005Date of Patent: June 29, 2010Assignee: Minu LLCInventor: Gholam A. Peyman
-
Patent number: 7341599Abstract: An intraocular lens for modifying the refractive abilities of a natural lens or an existing artificial lens in an eye to correct for vision disorders such as presbyopia, myopia, hyperopia or astigmatism. Specifically, the lens system can be configured so that it does not effect far vision, while effecting near vision using a plus lens to correct for presbyopia. The lens system includes a lens portion and fastening members, with the lens portion being movably secured to at least one of the fastening members so that the position of the lens portion can be modified with respect to the optical axis, and the overall length of the lens system can be increased or decreased.Type: GrantFiled: May 13, 2003Date of Patent: March 11, 2008Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Publication number: 20080039769Abstract: The present invention relates to a system for treating a patient. The system includes a device configured to be positioned adjacent a portion of the patient, a medicinal substance delivery device, adapted to delivery a medicinal substance to the portion of the patient, a heating means adapted to provide heat to the device and a control system configured to monitor the heating means and control the temperature of the device at the portion of the patient.Type: ApplicationFiled: November 21, 2006Publication date: February 14, 2008Applicant: MINU LLCInventor: Gholam A. Peyman
-
Publication number: 20070142828Abstract: The present invention relates to a system for altering the refractive properties of an eye. The system includes a device configured to be positioned adjacent a portion the cornea of the eye, a cross linker, adapted to be applied to the cornea, a device for emitting ultraviolet rays at the cornea, and a control system configured to monitor the emitting device.Type: ApplicationFiled: February 20, 2007Publication date: June 21, 2007Applicant: Minu, LLCInventor: Gholam Peyman
-
Publication number: 20070142909Abstract: A lens system is provided. The lens system includes a lens adapted to be positioned along the main optical axis of the eye and a control unit. The control unit is operable with the lens to alter the focal length of the lens based at least partly upon a condition, such that the lens alters light rays and focuses the rays on the retina of the eye.Type: ApplicationFiled: June 23, 2006Publication date: June 21, 2007Applicant: Minu LLCInventor: Gholam PEYMAN
-
Patent number: 7220224Abstract: The present invention relates to a method of displacing an area of the macula of an eye, including the steps of placing a substance below the surface of the retina, folding the retina to form a folded portion of the retina, and affixing the folded portion, so that the folded portion substantially maintains a folded shape.Type: GrantFiled: July 24, 2003Date of Patent: May 22, 2007Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Publication number: 20070088415Abstract: The present invention relates to a device for treating the eye, including a body portion configured to be positioned adjacent the exterior surface of the cornea and a heating means for heating the body portion to a predetermined temperature to affect at least one of the following: facilitation of the escape of aqueous humor from the eye and substantially preventing coagulation of the corneal tissue, while substantially destroying tumor cells.Type: ApplicationFiled: November 10, 2006Publication date: April 19, 2007Applicant: MINU LLCInventor: Gholam Peyman
-
Patent number: 7147636Abstract: A device for reshaping the cornea to correct the refractive error thereof. A first electrode is adapted to be heated and inserted into the corneal stroma of the eye, thereby reshaping a portion of the cornea. A second electrode is adapted to be heated and inserted into the corneal stroma of the eye, thereby reshaping a portion of the cornea. A member couples the first and the second electrodes together, allowing for change of the refractive power of the cornea, while avoiding irregular shrinkage of the corneal tissue.Type: GrantFiled: September 19, 2002Date of Patent: December 12, 2006Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 6989008Abstract: A method of modifying a cornea of an eye to reduce refractive error, the cornea having a surface and a main optical axis, including the steps of aiming and firing a laser at the cornea of the eye. The laser first separates an internal portion of the cornea forming a first internal surface and a second internal surface, the first internal surface facing in a posterior direction of the cornea and the second internal surface facing in an anterior direction of the cornea, with the first and second internal surfaces forming an internal pocket therebetween. An incision is then made from the surface of the cornea to the internal pocket, and an ocular implant is introduced through the incision and into the internal pocket of the cornea.Type: GrantFiled: March 23, 2001Date of Patent: January 24, 2006Assignee: Minu LLCInventor: Gholam A. Peyman
-
Patent number: 6942655Abstract: Age-related macular degeneration (AMD) results in the formation of new blood vessels in the eye. The walls of these vessels leak fluid, which causes scarring in the surrounding tissue and results in reduced vision or loss of vision. Photodynamic therapy (PDT) alone has been used to treat AMD, but many retreatments are needed, which cause further damage to the already diseased area. Laser treatment to coagulate the fluid actually causes additional new vessels to form. However, the inventive method of treating patients with both PDT and scatter threshold laser coagulation therapy surprisingly either improved vision, or prevented further loss of vision. Moreover, the combined treatment eliminated the need for retreatment, and did not generate new vessel growth. Threshold laser coagulation and PDT may be administered within the same treatment session or either may be administered first and the other may be administered within ninety days.Type: GrantFiled: March 27, 2002Date of Patent: September 13, 2005Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 6936043Abstract: Age-related macular degeneration (AMD) results in the formation of new blood vessels in the eye. The walls of these vessels leak fluid, which causes scarring in the surrounding tissue, resulting in reduced vision or loss of vision. Photodynamic therapy (PDT) alone has been used to treat AMD, but many retreatments are needed, which cause further damage to the already diseased area. Laser treatment to coagulate the fluid actually causes additional new vessels to form. However, the inventive method of treating patients with both PDT and laser coagulation surprisingly either improved vision, or prevented further loss of vision. Moreover, the combined treatment eliminated the need for retreatment, and did not generate new vessel growth. Laser coagulation and PDT may be administered within the same treatment session or either may be administered first and the other may be administered within ninety days.Type: GrantFiled: November 13, 2001Date of Patent: August 30, 2005Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 6855163Abstract: A system adapted to modify refractivity of a cornea of an eye, including a first component, and adapted to be implanted at a first depth in the cornea. A second component, separate from the first component, is adapted to be implanted at a second depth in the cornea at a position relative to the first component, such that an axis passing through the eye parallel to the optical axis passes through the second component without passing through the first component. The second depth is closer to the front surface of the cornea than is the first depth.Type: GrantFiled: July 19, 2002Date of Patent: February 15, 2005Assignee: Minu, LLCInventor: Gholam A. Peyman